 "GSK to set up Rs 1000-cr pharma plant in Bengaluru")
GlaxoSmithKline Pharmaceuticals (GSK Pharma) will invest Rs 1000 crore in a greenfield manufacturing facility at Vemgal near Bengaluru - the first greenfield pharma site GSK has built across the globe over the past 10 years, according to a PTI report.
The proposed plant, having an installed capacity of over 9 billion tablets and capsules per year, is expected to be operational by 2017.
The new unit is part of the strategic plan to rationalise, streamline and reduce costs in the supply network, while increasing capacity to meet the growing demands for important medicines, said the company in its annual report.
In addition, GSK India is also upgrading its Nashik site in Maharashtra by investing in infrastructure across all areas with special focus on good manufacturing practices (GMP), safety and sustainability, added the report.
FOR COMPLETE REPORT READ: GSK Pharma's Bengaluru facility to be operational by 2017
The proposed plant, having an installed capacity of over 9 billion tablets and capsules per year, is expected to be operational by 2017.
The new unit is part of the strategic plan to rationalise, streamline and reduce costs in the supply network, while increasing capacity to meet the growing demands for important medicines, said the company in its annual report.
In addition, GSK India is also upgrading its Nashik site in Maharashtra by investing in infrastructure across all areas with special focus on good manufacturing practices (GMP), safety and sustainability, added the report.
FOR COMPLETE REPORT READ: GSK Pharma's Bengaluru facility to be operational by 2017
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%